Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamdy A Azim

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Chinese Clinical Oncology|April 6, 2015
Commentary on "aTTom": long-term effects of continuing adjuvant Tamoxifen to 10 yearsHamdy A Azim, Ahmed Saadeldeen
Journal of Thoracic Disease|August 6, 2014
Breast cancer in Egypt, China and Chinese: statistics and beyondHamdy A Azim, Amal S Ibrahim
Journal of the Egyptian National Cancer Institute|August 5, 2009
Review article optimizing the use of her-2/neu targeting agents in breast cancer : a developing nation perspectiveHamdy A Azim, Hatem A Azim
Future Oncology (London, England)|February 17, 2012
Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directionsHamdy A Azim, Hatem A Azim
Chinese Clinical Oncology|January 14, 2021
Integrating PARP inhibitors into the management of breast cancer: where are we?Hamdy A Azim, Loay Kassem, Hatem Azim
The Breast Journal|July 13, 2018
Treatment of HER2-positive early breast cancer: How to best balance efficacy and toxicity?Hamdy A Azim, Shaimaa Lasheen, Loay Kassem
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2010
The Abu Dhabi declaration: why the hustle?Hamdy A Azim, Abdul-Rahman Jazieh, Mohammad Jahanzeb
Clinical Breast Cancer|September 11, 2017
Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus BiologyHamdy A Azim, Raafat Abdel-Malek, Loay Kassem
Onkologie|June 29, 2007
Imatinib in the treatment of follicular dendritic sarcoma: a case report and review of literatureHamdy A Azim, Ehab Elsedewy, Hatem A Azim
Women'S Health (London, England)|October 23, 2014
Pathological features and prognosis of lobular carcinoma in Egyptian breast cancer patientsHamdy A Azim, Raafat A Malek, Hatem A Azim
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Chinese Clinical Oncology|April 6, 2015
Commentary on "aTTom": long-term effects of continuing adjuvant Tamoxifen to 10 yearsHamdy A Azim, Ahmed Saadeldeen
Journal of Thoracic Disease|August 6, 2014
Breast cancer in Egypt, China and Chinese: statistics and beyondHamdy A Azim, Amal S Ibrahim
Journal of the Egyptian National Cancer Institute|August 5, 2009
Review article optimizing the use of her-2/neu targeting agents in breast cancer : a developing nation perspectiveHamdy A Azim, Hatem A Azim
Future Oncology (London, England)|February 17, 2012
Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directionsHamdy A Azim, Hatem A Azim
Chinese Clinical Oncology|January 14, 2021
Integrating PARP inhibitors into the management of breast cancer: where are we?Hamdy A Azim, Loay Kassem, Hatem Azim
The Breast Journal|July 13, 2018
Treatment of HER2-positive early breast cancer: How to best balance efficacy and toxicity?Hamdy A Azim, Shaimaa Lasheen, Loay Kassem
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2010
The Abu Dhabi declaration: why the hustle?Hamdy A Azim, Abdul-Rahman Jazieh, Mohammad Jahanzeb
Clinical Breast Cancer|September 11, 2017
Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus BiologyHamdy A Azim, Raafat Abdel-Malek, Loay Kassem
Onkologie|June 29, 2007
Imatinib in the treatment of follicular dendritic sarcoma: a case report and review of literatureHamdy A Azim, Ehab Elsedewy, Hatem A Azim
Women'S Health (London, England)|October 23, 2014
Pathological features and prognosis of lobular carcinoma in Egyptian breast cancer patientsHamdy A Azim, Raafat A Malek, Hatem A Azim
Pageof 4